Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The company could have supported us @ .50 volume Why not? / Bluewing

Yes, the shareholders would have to vote on a buy out.

However, us Joe Sixpacks control nothing as a huge block of shares that do not cast votes are automatically voted by the BOD.

IMO, nobody will buy us until many of the unknowns surface -- USPTO reviews, current litigation, S&L intentions & sales, new CEO, and,well, pick you posion for the near term.

Time will tell as the new license deals are announced, or not.

Longer term, I believe the revenues will be there to support a higher pps. How high is a WAG at best.

John

Share
New Message
Please login to post a reply